You are here

  • Home
  • Archive
  • Volume 73, Issue 6
  • Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al

Article Text

Article menu
Download PDFPDF
Electronic pages
Correspondence
Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al

https://doi.org/10.1136/annrheumdis-2014-205399

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles

    • Electronic pages
      Response to Dr Bredemeier's letter
      Edward M Vital Shouvik Dass Maya H Buch Andrew C Rawstron Paul Emery
      Annals of the Rheumatic Diseases 2014; 73 e34-e34 Published Online First: 14 Mar 2014. doi: 10.1136/annrheumdis-2014-205405